SANTA CLARA, Calif.,
March 22, 2017 /PRNewswire/
-- Based on its recent analysis of the diagnostic cardiology
solutions segment, Frost & Sullivan recognizes GE
Healthcare with the 2016 Global Frost & Sullivan Company of the
Year Award. GE Healthcare's strategy of innovating and expanding
its portfolio to offer end-to-end cardiac solutions has allowed it
to effectively compete in a mature, fragmented, and highly
competitive cardiac monitoring products space. In addition to
aiding patient and clinician workflows, ECG data integration, and
cardiac information distribution and analysis, GE Healthcare has
improved the clinical algorithms that help clinicians diagnose
conditions like sudden cardiac death and acute coronary syndrome.
These advancements have supported the early detection of cardiac
anomalies and lowered mortality rates.
Acknowledging that customers in developed, developing, and
emerging markets have various levels of technology shyness, GE
Healthcare provides not just devices or ECG boxes but wholesome and
affordable solutions. For example, ECG products intended for
emerging markets must be value-based ($1,000-$5,000), so GE manufactures them closer to
the end-user customers, such as in India and China. GE Healthcare is also bridging the
resource gaps in these countries by connecting primary care clinics
with cardiologists using cloud connected solutions and offering
clinical education programs, both in-classroom and online.
"Significantly, GE Healthcare's 2016 iteration of its MUSE (MUSE
V9) data management system facilitates bi-directional flow of data
with non-GE ECG systems. This process reduces the overall cost to
end users, as it plugs the communication gaps among vendors,
modalities, clinics, and hospitals and decreases the need for
recurring investments," said Frost & Sullivan Industry Analyst
Poornima Srinivasan. "Its numerous
benefits, such as workflow flexibility, faster decision making,
integration with hospital information systems, and electronic
medical record (EMR), keep GE Healthcare's advanced platform a step
ahead of the competition."
Apart from organic growth, GE Healthcare has pursued
relationships with distributors in countries such as India, China,
and Latin America, and reached
across to Tier II, III, and IV customers. As the company operates
within a diverse customer base, it customizes its business models
and products to deliver the best-fit diagnostic cardiology
solutions to clients.
GE Healthcare has adopted several strategic methods such as
addressing the challenges of connectivity and effective workflow to
grow in the emerging economies of Asia-Pacific and Latin America. Furthermore, its knowledge of
the needs of research universities and hospitals in the United States enable it to introduce many
products including resting ECG, stress ECG, the Holter monitor, and
data management systems. Last, its global footprint ensures the
advantage of connecting across developed, developing, and emerging
regions, optimizing solutions and designing futuristic
products.
GE Healthcare's offers a wide range of capabilities in this
space:
- strategies for the benefit of customers through basic
acquisition algorithms
- algorithms for cardiologists to interpret ECGs
- comparisons of ECG with prior ECG waveform
- functions that predict sudden cardiac death and acute coronary
syndrome
- algorithms based on gender
"GE Healthcare creates a rich ownership experience for its
customers by engaging with end users right from the product
development stage," noted Srinivasan. "Its technological abilities
and continuous upgrades of services facilitate integration with the
cardiology solutions of multiple vendors, creating a flexible
interface and reducing the capital investment requirements."
For its focus on driving business performance by innovating for
the future, Frost & Sullivan is pleased to recognize GE
Healthcare with the prestigious 2016 Global Frost & Sullivan
Company of the Year Award.
Each year, Frost & Sullivan presents this award to the
company that demonstrates excellence in terms of growth strategy
and implementation. The award recognizes a high degree of
innovation with products and technologies and the resulting
leadership in terms of customer value and market penetration.
Frost & Sullivan Best Practices awards recognize companies
in a variety of regional and global markets for demonstrating
outstanding achievement and superior performance in areas such as
leadership, technological innovation, customer service, and
strategic product development. Industry analysts compare market
participants and measure performance through in-depth interviews,
analysis, and extensive secondary research to identify best
practices in the industry.
About GE Healthcare
GE Healthcare provides
transformational medical technologies and services to meet the
demand for increased access, enhanced quality and more affordable
healthcare around the world. GE (NYSE: GE) works on things that
matter - great people and technologies taking on tough challenges.
From medical imaging, software & IT, patient monitoring and
diagnostics to drug discovery, biopharmaceutical manufacturing
technologies and performance improvement solutions, GE Healthcare
helps medical professionals deliver great healthcare to their
patients. For more information about GE Healthcare, visit our
website at www.gehealthcare.com.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in
collaboration with clients to leverage visionary innovation that
addresses the global challenges and related growth opportunities
that will make or break today's market participants. For more than
50 years, we have been developing growth strategies for the global
1000, emerging businesses, the public sector and the investment
community. Contact us: Start the discussion.
Contact:
Chiara Carella
P: +44 (0) 207.343.8314
F: 210.348.1003
E: chiara.carella@frost.com
Elizabeth Smith
GE Healthcare
+1 617 872 1214
Elizabeth.Smith@ge.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/frost--sullivan-applauds-ge-healthcares-visionary-innovation-strategy-in-providing-end-to-end-cardiac-diagnostic-solutions-globally-300427251.html
SOURCE Frost & Sullivan